We have examined the pathophysiological role of readmission of oxygen (and hence production of oxygen-derived free radicals) in the initiation of reperfusion-induced arrhythmias by separating, on a temporal basis, readmission flow from readmission of oxygen. Isolated rat hearts (n=12/group) were subjected to 10 minutes of regional ischemia and 10 minutes of reperfusion. In controls reperfused with oxygenated solution (Po2>600 mm Hg), 92% of hearts developed ventricular fibrillation (VF) during the first 20 seconds of reperfusion, whereas in hearts reperfused with hypoxic solution (Po2 9.3-12.2 mm Hg), the incidence of VF was only 17% (p<0.05). Subsequent readmission of control solution (Po2>600 mm Hg) to the latter group led, within 20 seconds, to the appearance of VF in seven of the 10 hearts (701%) that had not previously fibrillated. To examine whether hypoxic reperfusion had prevented VF or merely delayed its onset, the studies were repeated in separate groups of hearts with the duration of hypoxic reperfusion extended to 5 minutes. In addition, to examine the partial pressure dependence of the relation, the Po2 in the reperfusion solution was set at one of five different levels: greater than 600, 150-192.7, 69-85.6, 9.2-14.8, or 0.0 mm Hg. It was found that hypoxia merely delayed VF onset by 20-40 seconds and did not significantly reduce the incidence of VF, which was 83%, 92%, 67%, 58%, and 58%, respectively. This indicated that readmission of oxygen is unnecessary for the initiation of VF during reperfusion. The hearts that reverted to sinus rhythm during the ensuing 5 minutes (n=8, 4, 5, 9, and 8, respectively) were used to assess the arrhythmogenic consequences of readmission of oxygen. When control solution (Po2>600 mm Hg) was readmitted, new episodes of VF were elicited within 20 seconds in a manner that was inversely proportional to the preceding Po2 (p<0.05), the incidence of new episodes of VF being O0o, 0%1, 401%, 67%, and 86%, respectively. The arrhythmogenic effect of readmission of oxygen was not the result of a sudden increase in heart rate, because a similar arrhythmogenic effect of readmission of oxygen was seen in separate groups of hearts that were paced (350 beats/min) throughout hypoxia and readmission of oxygen. In conclusion, readmission of flow and readmission of oxygen are independent determinants of reperfusion-induced arrhythmias. However, because reperfusion can lead to VF even when Po2 is 0.0 mm Hg, it can be concluded that readmission of oxygen is not a prerequisite for arrhythmogenesis and that any intervention with specific and selective ability to prevent oxygen free radical toxicity cannot by itself be expected to attenuate reperfusion-induced arrhythmias. This implies that antiarrhythmic effects of anti-oxygen-radical interventions, reported in the past, result in part from actions unrelated to inhibition of the production or the effects of oxygen-derived free radicals. Oxygen-derived free radicals are capable of playing some contributory role to the initiation of reperfusion-induced arrhythmias, but the relevance of this mechanism is limited; it would appear to operate in parallel with other mechanisms of equivalent or greater malevolence that act independently. (Circulation Research 1990;67:1211-1224 eperfusion of ischemic myocardium can elicit involved. The pathophysiological mechanisms re-R serious ventricular arrhythmias.1,2These ar-sponsible for reperfusion-induced arrhythmias are rhythmias are inhibited by few drugs that not yet resolved. A number of hypotheses have been influence ischemia-induced arrhythmias,1 suggesting proposed, including disturbance of cyclic nucleotide that multiple pathophysiological mechanisms may be
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Pathophysiological Relevance of Oxygen-Derived Free Radicals to Arrhythmogenesis Makoto Yamada, David J. Hearse, and Michael J. Curtis We have examined the pathophysiological role of readmission of oxygen (and hence production of oxygen-derived free radicals) in the initiation of reperfusion-induced arrhythmias by separating, on a temporal basis, readmission flow from readmission of oxygen. Isolated rat hearts (n=12/group) were subjected to 10 minutes of regional ischemia and 10 minutes of reperfusion. In controls reperfused with oxygenated solution (Po2>600 mm Hg), 92% of hearts developed ventricular fibrillation (VF) during the first 20 seconds of reperfusion, whereas in hearts reperfused with hypoxic solution (Po2 9.3-12.2 mm Hg), the incidence of VF was only 17% (p<0.05). Subsequent readmission of control solution (Po2>600 mm Hg) to the latter group led, within 20 seconds, to the appearance of VF in seven of the 10 hearts (701%) that had not previously fibrillated. To examine whether hypoxic reperfusion had prevented VF or merely delayed its onset, the studies were repeated in separate groups of hearts with the duration of hypoxic reperfusion extended to 5 minutes. In addition, to examine the partial pressure dependence of the relation, the Po2 in the reperfusion solution was set at one of five different levels: greater than 600, 150-192.7, 69-85. 6, 9.2-14.8, or 0.0 mm Hg. It was found that hypoxia merely delayed VF onset by 20-40 seconds and did not significantly reduce the incidence of VF, which was 83%, 92%, 67%, 58%, and 58%, respectively. This indicated that readmission of oxygen is unnecessary for the initiation of VF during reperfusion. The hearts that reverted to sinus rhythm during the ensuing 5 minutes (n=8, 4, 5, 9, and 8, respectively) were used to assess the arrhythmogenic consequences of readmission of oxygen. When control solution (Po2>600 mm Hg) was readmitted, new episodes of VF were elicited within 20 seconds in a manner that was inversely proportional to the preceding Po2 (p<0.05), the incidence of new episodes of VF being O0o, 0%1, 401%, 67%, and 86%, respectively. The arrhythmogenic effect of readmission of oxygen was not the result of a sudden increase in heart rate, because a similar arrhythmogenic effect of readmission of oxygen was seen in separate groups of hearts that were paced (350 beats/min) throughout hypoxia and readmission of oxygen. In conclusion, readmission of flow and readmission of oxygen are independent determinants of reperfusion-induced arrhythmias. However, because reperfusion can lead to VF even when Po2 is 0.0 mm Hg, it can be concluded that readmission of oxygen is not a prerequisite for arrhythmogenesis and that any intervention with specific and selective ability to prevent oxygen free radical toxicity cannot by itself be expected to attenuate reperfusion-induced arrhythmias. This implies that antiarrhythmic effects of anti-oxygen-radical interventions, reported in the past, result in part from actions unrelated to inhibition of the production or the effects of oxygen-derived free radicals. Oxygen-derived free radicals are capable of playing some contributory role to the initiation of reperfusion-induced arrhythmias, but the relevance of this mechanism is limited; it would appear to operate in parallel with other mechanisms of equivalent or greater malevolence that act independently. (Circulation Research 1990;67:1211-1224) eperfusion of ischemic myocardium can elicit involved. The pathophysiological mechanisms re-R serious ventricular arrhythmias.1,2These ar-sponsible for reperfusion-induced arrhythmias are rhythmias are inhibited by few drugs that not yet resolved. A number of hypotheses have been influence ischemia-induced arrhythmias,1 suggesting proposed, including disturbance of cyclic nucleotide that multiple pathophysiological mechanisms may be metabolism,3 activation of adrenoceptors,4 and accu-mulation of amphiphiles,5 all of which have been linked with electrophysiological disturbance. 6 Most of these hypotheses center around the concept of substances being washed out of ischemic tissue during reperfusion to cause arrhythmias or substances being generated during reperfusion to cause arrhythmias. Any rational approach to development of therapy against reperfusion-induced arrhythmias requires that the relative importance of these substances be identified. For any candidate the two critical questions that must be answered are 1) does the substance play an independent role in arrhythmogenesis and 2) does the substance play the principal or pivotal role in arrhythmogenesis. The present study is focused on one particular candidate, the oxygen-derived free radical. Recent interest has focused on the suggestion that oxygen-derived free radicals may play a role in the initiation of reperfusion-induced arrhythmias.1"7 Support for this hypothesis has been provided by the observation that antioxidant enzymes,8 free radical scavengers,7 desferrioxamine,8 and spintrapping agents9,10 can inhibit reperfusion-induced ventricular fibrillation in the isolated perfused rat heart. The weakness of this evidence, as carefully pointed out in most of the above-mentioned studies, is that it is circumstantial; it could be argued that the antiarrhythmic activity of these interventions is derived from secondary pharmacological properties. The hypothesis is given independent support from evidence that free radical-generating systems can induce potentially arrhythmogenic changes in ventricular action potential configuration'1 and increase susceptibility to reperfusioninduced ventricular fibrillation (VF).8 However, this evidence, too, is circumstantial. Even experiments showing that oxygen-derived free radical generators can elicit arrhythmias in hearts not subjected to ischemia and reperfusion fail to consolidate the role of oxygen-derived free radicals in the initiation of reperfusion-induced arrhythmias, because the characteristics of arrhythmias elicited by oxygen-derived free radical generators differ greatly from the characteristics of arrhythmias elicited by ischemia and reperfusion, especially with respect to ventricular tachycardia (VT) and VF; VT is common, but VF is rare or absent with oxygen-derived free radical generation in the absence of ischemia and reperfusion,11"2 but both are equally common during reperfusion of the ischemic myocardium at the peak period of susceptibility to arrhythmias (e.g., see Ref- erence 13) . The weakness of the evidence in support of the oxygen-derived free radical hypothesis has recently been reviewed.14 Because so much evidence exists for a role for oxygen-derived free radicals in the pathogenesis of reperfusion-induced arrhythmias, yet so much of it is circumstantial and open to alternative interpretation, we decided to approach the question from a slightly different angle. A critical but hitherto lacking piece of evidence necessary to support a role for oxygenderived free radicals is a demonstration that arrhyth-mia susceptibility is dependent on the presence of oxygen in the reperfusion solution. According to the oxygen-derived free radical hypothesis, susceptibility to reperfusion-induced arrhythmias ought to be directly proportional to a positive power function (greater than or equal to 1) of Po2. If it were found to be the case that reperfusion-induced arrhythmias could be elicited in the absence of readmission of oxygen, then the oxygen-derived free radical hypoth-esis17 would no longer be tenable.
In the present study, therefore, our objective was to examine whether readmission of oxygen (a prerequisite for reperfusion-induced production of oxygenderived free radicals15) contributes independently to the initiation of reperfusion-induced arrhythmias. To achieve this, we have dissociated readmission of oxygen from readmission of flow. Recent electron spin resonance analysis of N-tert-butyl-a-phenylnitrone spin-adducts has shown that reperfusion of globally ischemic isolated rat hearts leads to production of free radicals only when oxygen is present during reperfusion and not when oxygen is absent. 15 We have repeated and extended the protocol of Garlick et al'5 with the same species (the rat) and a similar duration of ischemia (peak susceptibility to reperfusion-induced arrhythmias occurs 10-15 minutes after the onset of ischemia). The protocol was modified in only one major respect; we used regional instead of global ischemia to preclude complications associated with sinus and atrioventricular ischemia (e.g., sinus bradycardia and atrioventricular block) and to provide a more pathophysiologically relevant model. A 10-minute duration of ischemia was chosen to mimic conditions in which anti-oxygen-derived free radical interventions show substantial antiarrhythmic activity in this model (e.g., see Reference 8). The hypothesis that production of oxygen-derived free radicals is a major factor in the initiation of reperfusion-induced arrhythmias predicts that arrhythmias will occur only after readmission of oxygen and that their incidence will be directly proportional to a positive power function (greater than or equal to 1) of the Po2 of the reperfusion solution.
Materials and Methods Animals
Male Wistar rats (220-260 g body weight), obtained from Bantin and Kingman, Inc., Hull, UK, were used for all studies. Rats were used because 1) reperfusion-induced arrhythmias are reproducible,"13 2) collateral flow is negligible,6"17 3) coronary steal does not occur during constant pressure perfusion,18 and 4) small heart size makes their use convenient. The rats were maintained in compliance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1985).
Experimental Procedures
The techniques used for production and assessment of reperfusion-induced arrhythmias have been described in full elsewhere.13"19-21 Heparin (200 IU i.v.) was administered to the animal anesthetized with diethyl ether, and 30 seconds later the heart was excised and placed in cold (40 C) perfusion solution. The heart was perfused in the Langendorff mode at a constant perfusion pressure equivalent to 100 cm H20 with solution containing (in mM) NaCl 118.5, NaHCO3 25.0, KCI 3.2, MgSO4 1.19, KH2PO4 1.18, CaCl2 1.25, and glucose 11.1, gassed with 95% 02 plus 5% C02, pH 7.4, 370 C. Before use, all solutions were filtered through a 5 -,m-pore filter to remove any particulate contaminants.
A traction-type occluder was placed loosely around the left main coronary artery; 10 minutes later the occluder was tightened to induce regional ischemia. After 10 minutes, the occluded zone was reperfused by releasing the traction. We chose 10 minutes of ischemia for the following reasons. First, susceptibility to reperfusion-induced arrhythmias is dependent on the duration of preceding ischemia; in the isolated rat heart peak susceptibility occurs 10 minutes after the onset of ischemia.' Second, oxygen-dependent production of free radicals has been shown to occur in hearts reperfused after 10 minutes of ischemia. 15 In every experiment, coronary flow was recorded by timed collection of coronary effluent. This represents ventricular coronary flow because rat atria are superfused (rather than perfused) during Langendorff perfusion13; rat atria receive their blood supply from extracoronary vessels. 22 Stainless steel wire electrodes (one inserted into the ventricular apex, the other attached to the stainless steel aortic cannula) were used to obtain the electrogram (ECG), which was continuously displayed on a storage oscilloscope. Permanent ECG records were obtained by continuous and concurrent chart recording.
At the end of each experiment, reperfusion was confirmed and quantified by the dye-exclusion tech-nique13 with Disulphine blue (ICI, Macclesfield, UK) diluted 5:1,000 (vol/vol) in 0.9% saline. Uniform staining was taken to indicate effective reperfusion.
Definitions of Normoxia, Hypoxia, and Anoxia
The Po2 of the control perfusion solution used in this and all previous studies (greater than 600 mm Hg) greatly exceeds arterial Po2 in vivo. For this reason the control solution can be regarded as hyperoxic. However, in the context of water-based perfusion of isolated hearts, it is normoxic. Use of solutions with such high Po2 in perfused hearts can be justified by the absence of hemoglobin and the resultant intrinsic deficiency in oxygen delivering capacity of water-based solutions. The complete absence of arrhythmias during control perfusion and general long-term stability of isolated heart prepara-tions23 indicates that standard control perfusion so-lutions with P02 values of greater than 600 mm Hg are not intrinsically toxic. For this reason we have defined the control solution (Po2>600 mm Hg) as normoxic. Solutions found to have a Po2 below the limit of detection of our blood gas analyzer (approximately 0.0 mm Hg) are referred to as anoxic (defined as Po2<0.0 mm Hg). Solutions with intermediate P02 values are referred to as hypoxic.
Modification of Po2
The P02 of the perfusion solutions was regulated by gassing the perfusion solution with different combinations of 95% 02 plus 5% C02, and 95% N2 plus 5% CO2. In addition, very low levels of Po2 (<0.0 mm Hg) were achieved by combining N2 plus CO2 and gassing with the addition of 0.5 mM sodium dithionite. At the beginning of each experiment (after allowing 15-20 minutes for equilibration), Po2 levels were measured by allowing perfusion solution to flow through the aortic cannula at a rate similar to expected coronary flow (10-15 ml/min) and collecting the effluent in a glass syringe for immediate analysis (Nova Statprofile I, V.A. Howe Ltd., London). Standard control perfusion solution was found to have a Po2 that always exceeded 600 mm Hg.
To ensure that the Po2 of the solution entering the heart was at the desired level at the moment of reperfusion, it was necessary to switch solutions before reperfusion. The dead space between the heart and the control and test solutions was less than 0.1 ml. Because coronary flow in the regionally ischemic isolated rat heart ranges from approximately 3 to 6 ml/min, depending on the experimental conditions, we calculated that 15 seconds would be sufficient time to ensure complete washout of control solution from the dead space proximal to the occluder and from the adjacent nonischemic tissue. In preliminary experiments, we found that an equivalent period of global hypoxia had no effect on hemodynamics and did not itself elicit arrhythmias.
Experimental Protocol
The studies had two simple objectives. The first was to test whether the occurrence of reperfusioninduced arrhythmias requires the presence of oxygen (and to determine the concentration dependence of the relation, if any). To achieve this, we reperfused regionally ischemic hearts with solution containing reduced Po2. The second objective was to examine whether readmission of oxygen constitutes an arrhythmogenic stimulus that is independent of other arrhythmogenic components of reperfusion (and to determine the concentration dependence of the relation, if any). This was achieved by readmitting normoxic solution after a period of hypoxic reperfusion.
All groups consisted of 12 hearts (unless indicated otherwise). The experiments were performed according to three protocols. The protocols are schemati- cally represented in Figure 1 . For each protocol, hearts were assigned to groups by randomization. Transient hypoxic reperfusion (protocol 1). In protocol 1, two groups of hearts were examined. Controls (Po2>600 mm Hg) were compared with hearts reperfused with hypoxic solution (P02 9.3-12.2 mm Hg). In the latter group, normoxic solution was readmitted 20 seconds after reperfusion. In both groups, the total duration of reperfusion was 10 minutes. This protocol permitted an examination of 1) whether brief hypoxia could prevent reperfusion arrhythmias and 2) whether readmission of oxygen could elicit arrhythmias subsequent to and independently of the restoration of coronary flow. The short duration of hypoxic reperfusion (20 seconds) was chosen to preclude any complications associated with secondary effects of hypoxia itself. However, this introduced an unavoidable disadvantage to the protocol in that if it were found that hypoxic reperfusion attenuated reperfusion-induced arrhythmias and readmission of normoxic solution initiated arrhythmias, it could be argued that hypoxia was merely delaying the onset of reperfusion arrhythmias, not preventing them. This issue was addressed in a further series of experiments (protocol 2).
Prolonged hypoxic reperfusion and Po2 partial pressureresponse relation (protocol 2). In protocol 2, we extended the duration of hypoxic reperfusion to 5 minutes. Furthermore, we varied the Po2 over a wide range to determine the partial pressure-response relation. Five different levels of Po2 were achieved (in mm Hg): >600 (normoxia), 150-192.7, 69-85.6, 9.2-14.8 (three levels of hypoxia), and <0.0 (anoxia). The three levels of hypoxia were chosen on the basis of preliminary experiments in which it was found that such values (approximating Po2 values of 170, 75, and 10 mm Hg) could be achieved reliably and reproducibly by adjusting the gas presettings to specific levels. Values of Po2 between 192.7 and 600 mm Hg were not examined because such values fall between the normoxic value for crystalloid solutions and the normoxic value for blood and were considered unlikely to provide any useful information relating to reperfusion-induced arrhythmias and readmission of oxygen. As mentioned above, anoxia was achieved by adding 0.5 mM sodium dithionite to solution gassed with 95% N2 plus 5% CO2. Conceivably, any observed reduction in reperfusion-induced arrhythmias with anoxic solution could be attributable to the presence of dithionite. Therefore, we included an additional group of hearts in which reperfusion was carried out with solution containing 0.5 mM sodium dithionite but which was gassed with 95% 02 plus 5% C02, giving a normoxic Po2 (greater than 600 mm Hg).
Extending the duration of hypoxic reperfusion potentially resolved any ambiguity arising from protocol 1 concerning whether hypoxic reperfusion prevented or merely delayed reperfusion-induced arrhythmias and whether readmission of oxygen initiated arrhythmias independently of reperfusion. However, this protocol had two potential disadvantages of its own. First, the protocol significantly extended the effective duration of oxygen deprivation in the occluded region to 15 minutes (10 minutes of ischemia plus 5 minutes of hypoxia), giving rise to the argument that readmission of oxygen was being carried out at a time when hearts had become less susceptible to arrhythmias owing to the existence of the so-called bell-shaped time-response curve relating the duration of ischemia to susceptibility to reperfusion-induced arrhythmias.1 However, this can be discounted, because susceptibility to reperfusioninduced arrhythmias after 10 minutes of ischemia is identical to susceptibility after 15 minutes of ischemia in the isolated rat heart (e.g., see Reference 13) . Second, because hypoxic or anoxic reperfusion involves perfusion of the entire heart with hypoxic or anoxic solution, the nonischemic region is effectively subjected to 5 minutes of hypoxia or anoxia. Long periods (30 minutes) of hypoxia can predispose 9. hearts to arrhythmias during readmission of oxygen.24,25 It is not known whether such arrhythmias occur with shorter periods of hypoxia or anoxia (e.g., 5 minutes). Severe arrhythmias during readmission of oxygen after 5 minutes of hypoxia would make the interpretation of the results from protocol 2 difficult. To determine whether any arrhythmias occurring during readmission of oxygen subsequent to 5 minutes of hypoxic or anoxic reperfusion were dependent on prior exposure to regional ischemia and not related to effects of the global hypoxia/anoxia per se, we have included an additional group of hearts (n =6) that were not exposed to regional ischemia but perfused for 5 minutes with anoxic solution (Po2<0.0 mm Hg) followed by readmission of normoxic solution (Po2>600 mm Hg).
Controlfor bradycardia (protocol 3). Global hypoxia causes bradycardia. Initially, we were concerned that any antiarrhythmic effects caused by hypoxic reperfusion (especially prolonged hypoxic reperfusion, protocol 2) could conceivably be attributable to a reduction of heart rate during reperfusion. However, separate studies have shown that the presence of bradycardia during reperfusion does not reduce susceptibility to reperfusion-induced arrhythmias. 26, 27 More importantly, we were particularly concerned that possible heart rate changes could complicate the interpretation of any arrhythmogenic effects of readmission of oxygen, because it was expected that readmission of oxygen would elicit a sudden increase in heart rate via reoxygenation of the sinoatrial node. This would be expected to shorten action potential duration and refractory period28 and lower extracellular potassium concentration.29 These effects are potentially arrhythmogenic, precluding differentiation between a direct arrhythmogenic effect of readmission of oxygen and an indirect effect.
To control for bradycardia, three groups of hearts reperfused for 5 minutes with normoxic solution (Po2> 600 mm Hg), hypoxic solution (Po2 9.1-15 mm Hg), or anoxic solution (Po2<0.0 mm Hg) were subjected to left ventricular pacing at a rate (350 beats/min) just sufficient to overdrive the expected sinoatrial rate of 280-320 beats/min, for a period beginning 90 seconds before reperfusion and lasting throughout the entire 10-minute period of reperfusion (i.e., before, during, and after the readmission of oxygen). Identification, Quantification, and Statistical Analysis of Variables Arrhythmias were identified from the ECG and quantified in accordance with the Lambeth Conventions. 30 The time of onset and termination of VT and VF were noted. The incidences of VT and VF were calculated for each group. VT and VF incidences were analyzed using Mainland's contingency tables. 31 Gaussian-distributed variables (e.g., heart rate and coronary flow) were subjected to analysis of variance followed by a t test (modified as appropriate), if treatment constituted a significant source of vari-ance. Log1o transforms were used for certain variables (e.g., the time of onset of reperfusion-induced VF), according to criteria described previously.13
Results

Transient Hypoxic Reperfusion (Protocol 1)
Arrhythmias. To illustrate the major types and the onset and duration of arrhythmias occurring during reperfusion and readmission of oxygen, the time course of arrhythmias for individual hearts is shown in Figure 2 .
In control hearts reperfused with normoxic solution (Po2>600 mm Hg), ventricular arrhythmias were elicited in all hearts within 3 seconds of the start of reperfusion ( Figure 2 ). The pattern of arrhythmias consisted of a single uninterrupted paroxysm beginning with one to three ventricular premature beats (the duration of which was so brief that it is not possible to discern their presence in Figure 2 ), followed rapidly by VT and then VF. If VF selfterminated, no further reperfusion-induced arrhythmias occurred. The incidence of VT was 100% in control hearts ( Figure 2 ). The incidence of VF was also 100% in control hearts and occurred within 20 seconds of reperfusion in 92%. In contrast, when hypoxic solution (Po2 9.3-12.2 mm Hg) was used for the first 20 seconds of reperfusion, VF incidence was only 17% during this period ( Figure 2 ); this value was significantly lower than the control value (p<0.05). However, subsequent readmission of oxygen resulted in VF in 70% of the remaining 10 hearts that had not developed VF during the initial reperfusion with hypoxic solution. VF occurred within 15 seconds of readmission of oxygen in every instance. In the other three hearts that did not fibrillate, sinus rhythm resumed within 90 seconds of starting reperfusion. In contrast to its effect on VF, hypoxic reperfusion had no protective action on VT, which occurred within 5 seconds of reperfusion in 100% of the hearts. As in the control group, the pattern of arrhythmias represented a single uninterrupted paroxysm. Heart rate, coronary flow, and occluded zone size. The difference in susceptibility to VF between the two groups was not due to a difference in heart rate or coronary flow during the period of ischemia or during reperfusion or to differences in occluded zone size, because values were almost identical in controls and in the hypoxic group: heart rate was 279+10 and 292±11 beats/min, respectively, 1 minute before the start of reperfusion (too few hearts were in sinus rhythm 1 minute after the start of reperfusion to warrant calculation of mean+SEM values); coronary flow was 6.0+0.3 and 6.4±0.4 mlu min, respectively, 1 minute before the start of reperfusion and 12.0+0.5 and 12.5+±0.5 ml/min, respectively, 1 minute after the start of reperfusion; occluded zone size was 40.7±1.5% and 40.7±1.9%, respectively, of wet ventricular weight.
Prolonged Hypoxic Reperfusion and Po2 Partial Pressure-Response Relation (Protocol 2) Arrhythmias. The effects of 1) extending the duration of hypoxic reperfusion to 5 minutes to examine whether hypoxia prevents VF or merely delays VF onset and 2) varying the Po2 to examine any partial pressure-response relation are shown in Figures 3-5 . The antiarrhythmic effect of severely hypoxic solution (Po2 9.2-14.8 mm Hg) during the first 20 seconds of reperfusion (demonstrated in protocol 1) was confirmed (Figure 3 , top panel and fourth panel). Furthermore, it was also confirmed that VT incidence ( Figure 3 ) and the time of onset of the first reperfusion-induced arrhythmia (Figure 4 , top panel) were also unrelated to Po2. However, the results of protocol 2 also showed that hypoxic reperfusion did not prevent VF from occurring, but merely delayed its onset (Figure 4 compared with reperfusion at Po2>600 mm Hg). The incidences of reperfusion-induced VF occurring during the initial 5 minutes of reperfusion were not significantly different between the groups (Figure 5 ).
After 5 minutes of hypoxic reperfusion, normoxic control solution was readmitted. In hearts in which sinus rhythm had resumed (n=8, 4, 5, 9, and 8, in Reperfusion began at time zero and was continued for 600 seconds. All hearts were in sinus rhythm at the moment of reperfusion. The data have been arranged in relation to the order in which spontaneous restoration of sinus rhythm occurred, not in relation to the order in which the experiments were carried out (the study was randomized). It should be noted that ventricular tachycardia was commonly preceded by one to three ventricularpremature beats, but the duration of the latter was so brief that theirpresence is indiscemible in thefigure. Discontinuities on the time axis are indicated by diagonal slashes. Top panel: Hearts were reperfused with control solution (Po2>600 mm Hg). Bottom panel: The first 20 seconds of reperfusion was caried out using hypoxic solution (9.3 <Po2<12.2 mm Hg); this is indicated by the vertical line through the data at the 20-second mark. episodes of VT and VF (Figure 3 ). As with the arrhythmias resulting from reperfusion, these arrhythmias were characterized by 1) a rapid onset (within 15 seconds of readmission of oxygen) and 2) VF always being preceded by VT. Furthermore, the incidence of VF occurring during readmission of oxygen was inversely proportional to the Po2 present during the initial 5 minutes of reperfusion ( Figure 5 ). To reduce Po2 to less than 0.0 mm Hg in the experiments described, we used 0.5 mM sodium dithionite. In a separate group of hearts (n=6), we examined whether the effects of dithionite resulted indirectly from the low Po2 as intended or from some direct effect of dithionite itself. This was achieved by including 0.5 mM dithionite in reperfusion solution gassed with 95% 02 plus 5% CO2 to maintain Po2>600 mm Hg. We found that the effects of this solution resembled those of the control solution. Reperfusion elicited VT within 2 seconds in 100% of hearts. This was followed by VF in 100% of hearts. There was no delay in onset of VF in this group, because VF occurred within 20 seconds of reperfusion in every heart. Subsequent washout of dithionite 5 minutes after reperfusion did not elicit arrhythmias in any heart. Thus, the effects of reperfusion with solution containing Po2<0.0 mm Hg (shown in Figures 3-5) were entirely attributable to the low Po, and not to the presence of dithionite. Hypoxic and anoxic reperfusion necessitated exposing the heart to 5 minutes of global hypoxia or anoxia. To control for the possibility that the arrhythmias occurring during readmission of oxygen were related to the global hypoxia/anoxia and unrelated to the regional ischemia, we included an additional group of hearts (n=6) perfused for 5 minutes with anoxic solution followed by readmission of normoxic solution (without exposure to regional ischemia). Readmission of oxygen elicited VF and VT in 0% and 0% of hearts, respectively. Thus, the occurrence of VF and VT during readmission of oxygen subsequent to 5 minutes of hypoxic or anoxic reperfusion was dependent on prior exposure to regional ischemia and was not related to effects of the global hypoxia/anoxia per se. Heart rate, coronary flow, and occluded zone size. There were no differences in heart rate or coronary flow between the groups before or during occlusion (Tables 1 and 2 ). Coronary flow fell during occlusion and rose during the first minute of reperfusion in all groups ( Table 1 ). The increase in flow was significantly greater in the groups of hearts reperfused with anoxic and hypoxic solution compared with controls (p<0.05). Within these groups, however, we did not find any graded partial pressure-dependent relation between Po2 and coronary flow; highest coronary flow values were observed in the group reperfused with solution at Po2 150-192.7 mm Hg. Subsequent readmission of normoxic solution elicited a partial pressure-dependent increase in coronary flow (Table  1) ; the increment in flow was greatest in the group reperfused initially with anoxic solution (Po2<0.0 mm Hg). The group of hearts reperfused with normoxic solution containing dithionite exhibited values of coronary flow that resembled those in the control group (Table 1) , indicating that the effects of dithionite on coronary flow (like its effects on arrhythmias) were attributable to the low P02 and not to the presence of dithionite per se. The time of onset and Occluded zone size (OZ) is expressed as mean±SEM% of wet ventricle weight. Coronary flow values (mean+SEM) were recorded 1 minute before the onset of regional ischemia (1-1), 1 and 9 minutes after the onset of ischemia (1+1 and 1+9, respectively), and at 1, 4, 6, and 10 minutes after the onset of reperfusion (R+1, R+4, R+6, and R+10). Hearts in the group indicated by Po2>600-D were reperfused with solution containing 0.5 mM dithionite (equivalent to the Po2<0.0 mm Hg group) gassed with 5% CO2 and 95%O 2 to maintain Po2 above 600 mm Hg. In each group, normoxic control solution (Po2>600 mm Hg) was readmitted 5 minutes after the onset of reperfusion. *p<0.05 vs. Po2>600 mm Hg. Heart rate values (mean+SEM) were recorded 1 minute before the onset of regional ischemia (I-1), 1 and 9 minutes after the onset of ischemia (1+1 and 1+9, respectively), and at 1, 4, 6, and 10 minutes after the onset of reperfusion (R+1, R+4, R+6, and R+10). Values were calculated using only those hearts in sinus rhythm at the indicated time point. Hearts in the group indicated by Po2>600-D were reperfused with solution containing 0.5 mM dithionite (equivalent to the Po2<0.0 mm Hg group) gassed with 5% CO2 and 95% On to maintain Po2 above 600 mm Hg. In each group, normoxic control solution (Po2>600 mm Hg) was readmitted 5 minutes after the onset of reperfusion. *p<0.05 vs. Po2>600 mm Hg. the incidence of arrhythmias occurring during reperfusion and readmission of oxygen failed to correlate with coronary flow values (p>O0.05).
In the hearts reperfused with anoxic or hypoxic solution, which recovered sinus rhythm after the initial burst of reperfusion-induced arrhythmias, sinus rate subsequently fell (p<0.05) during the course of reperfusion ( Table 2 ). Whether this effect was gradedly partial pressure dependent is difficult to ascertain because the number of hearts in sinus rhythm (e.g., n=3 to 5 at 1 minute after the start of reperfusion, Figure 3) was too low for a reliable assessment. Sinus rate recovered during subsequent readmission of oxygen (Table 2) . Changes in heart rate occurred more slowly than changes in flow, as exemplified by values 1 minute after readmission of normoxic solution, which remained low in hearts hitherto perfused with anoxic and hypoxic solution ( Table 2 ). Heart rate in the group reperfused with normoxic solution containing dithionite was indistinguishable from that in the control group (Table 2) , indicating that the effects of dithionite on heart rate (like its effects on arrhythmias and coronary flow) were attributable to the low Po2 and not to the presence of dithionite per se. Because the burst of reperfusion-induced arrhythmias preceded bradycardia, there was clearly no relation between arrhythmias and heart rate.
There were no significant differences in occluded zone size between the groups (Table 1) .
Control for Bradycardia (Protocol 3)
Arrhythmias. To be certain that the effects of hypoxia and readmission of oxygen on arrhythmias were not secondary to changes in heart rate, we took three separate groups of hearts reperfused with normoxic (Po2>600 mm Hg), hypoxic (P02 9.1-15.1 mm Hg), or anoxic (Po2<0.0 mm Hg) solution and paced the ventricles at a rate (350 beats/min) slightly above ambient sinus rate beginning 90 seconds before reperfusion and lasting throughout reperfusion. The results were essentially identical to the results with the unpaced hearts in all important respects.
Arrhythmias occurred during reperfusion and readmission of oxygen as a single continuous paroxysm, with VF always preceded by VT. As in protocols 1 and 2, 100% of hearts developed VT within 2 seconds of reperfusion in each group. In the normoxic group, 100% developed VF within 20 seconds of reperfusion, whereas in the hypoxic and anoxic groups the values were only 25% (p<0.05) and 33% (p<0.05). As before, this represented merely a small delay in VF onset rather than a prevention of VF, because the incidences of VF during the entire 5 minutes of hypoxic reperfusion were the same (83% and 83%) in these groups.
After 5 minutes of hypoxic reperfusion, normoxic control solution was readmitted. In hearts in which sinus rhythm had resumed, this resulted in the appearance of de novo episodes of VT and VF. As was the case in unpaced hearts, these arrhythmias were characterized by 1) a rapid onset (within 15 seconds of readmission of oxygen) and 2) VF always being preceded by VT. The incidences of VT and VF occurring during readmission of oxygen were 100% and 100% in hearts reperfused with hypoxic solution and 100% and 66%, respectively, in hearts reperfused with anoxic solution. This ruled out the possibility that readmission of oxygen had elicited arrhythmias in protocol 2 indirectly by increasing heart rate.
Heart rate, coronary flow, and occluded zone size. There were no differences between the normoxic, hypoxic, and anoxic groups with respect to heart rate (all 350 beats/min during reperfusion and readmission of oxygen except when arrhythmias were present) or occluded zone size (41+1.4%, 41.3+1.3%, and 40.7+1.7% of total ventricular weight, respectively). Coronary flow values were similar in the three groups before occlusion and after occlusion, but were significantly higher during readmission of 02 in the hearts initially reperfused with hypoxic solution (12.9+1 ml/min) and with anoxic solution (13.7+±0.7 ml/min) compared with controls (10.8±+0.4 ml/min), as observed in the unpaced groups.
Discussion
The mechanisms responsible for arrhythmogenesis in any pathological setting can be conceptualized as having a primary electrophysiological basis and an underlying pathophysiological basis. The present study is concerned with the pathophysiological basis of reperfusion-induced arrhythmias. Of the many factors that may be involved (some possibilities were listed above), the one we chose to examine was oxygen-derived free radicals. A large body of evidence in support of the hypothesis that oxygenderived free radicals play a pivotal role in the initiation of reperfusion-induced arrhythmias has built up in recent years, and the subject has received a great deal of attention (see Reference 14 for review). Nevertheless, this evidence is circumstantial (as discussed below). In the present study, we examined the hypothesis further by reperfusing isolated rat hearts with hypoxic or anoxic solution. Our principal findings were as follows. Reperfusion of regionally ischemic hearts with hypoxic or anoxic solution caused a short delay (approximately 20 seconds) in the onset of VF but did not reduce the incidence of VF. Despite this, subsequent readmission of oxygen could elicit arrhythmias de novo. This arrhythmogenicity was directly related to the preceding Po2, with VF occurring in 100% of hearts during readmission of oxygen after an initial period of anoxic reperfusion (Po2<0.0 mm Hg). Therefore, the principal conclusion is that these data do not support the hypothesis that oxygen-derived free radicals play a pivotal role in the initiation of reperfusion-induced arrhythmias, because arrhythmias were not significantly attenuated by reperfusion conditions equivalent to those previously shown to suppress reperfusion-induced oxygen-derived free radical formation.
Evidence Supporting a Role for Oxygen-Derived Free Radicals in the Initiation of Reperfusion-Induced Arrhythmias
The pathophysiological mechanisms responsible for reperfusion-induced arrhythmias are not fully established. An attractive hypothesis is that readmission of oxygen leads to production of free radicals (e.g., superoxide and hydroxyl radicals) that, under conditions of impaired radical scavenging capacity, lead to sarcolemmal and/or sarcoplasmic reticular damage, which is capable of eliciting electrophysiological disturbances of sufficient magnitude to initiate arrhythmias. The hypothesis is supported by a large body of circumstantial evidence. This can be broadly classed into three groups: 1) anti-free radical interventions possess antiarrhythmic activity (e.g., see Reference 7), 2) free radical-generating systems can potentiate reperfusion-induced arrhythmias,8 and 3) reperfusion causes the production of free radicals in a manner dependent on readmission of oxygen.15 This evidence is discussed in more detail as follows.
First, it has been shown that statistically significant reductions in the incidence of reperfusion-induced arrhythmias can be achieved with agents that either prevent the formation of oxygen-derived free radicals or scavenge them once they have been generated.
Effective interventions include allopurinol,32 superoxide dismutase,7 catalase, mannitol, methionine, glutathione, desferrioxamine,8 and the spin-traps N-tert-butyl-a-phenylnitrone9 and 5,5-dimethyl-1pyrroline N-oxide (DMPO).10 However, it can be argued that subsidiary actions of the interventions (unrelated to effects on oxygen-derived free radicals) were responsible for the protection. For example, in the case of allopurinol, purine salvage33 can be expected. In addition, in many studies8,32 interventions were present during the period of ischemia as well as during reperfusion, raising the possibility that protection was mediated by an anti-ischemic effect and unrelated to effects on oxygen-derived free radicals produced during reperfusion. In only a few studies has it been demonstrated that an intervention can produce a statistically significant reduction in reperfusion-induced VF when present only during the period of reperfusion, and in these studies, very high drug concentrations were required (e.g., References 9 and 10). Thus, while this evidence may support a role for oxygen-derived free radicals in the initiation of reperfusion-induced arrhythmias, the nature of this evidence is circumstantial.
Second, oxygen-dependent free radical generation can elicit electrophysiological dysfunction in the absence of ischemia or reperfusion,34 and free radicalgenerating systems have been shown to promote arrhythmias during reperfusion. As an example of the latter, FeCl3 ADP included in the reperfusion solution significantly increased the incidence of reperfusioninduced VF in isolated rat hearts.8 This effect was inhibited by pretreatment with catalase, mannitol, methionine, and desferrioxamine. However, to reveal the proarrhythmic effect of FeCl3 ADP, it was necessary to attenuate the effectiveness of reperfusion as an arrhythmogenic stimulus (i.e., manipulate the reperfusion conditions to lower the baseline incidence of reperfusion-induced VF). Therefore, these data do not unequivocally prove that oxygen-derived free radicals are the major cause of reperfusion arrhythmias; they simply show that oxygen-derived free radical production may potentiate the arrhythmogenic effects of reperfusion. From this it could be argued that the arrhythmogenic stimulus of reperfusion and the arrhythmogenic stimulus of oxygen-derived free radical production are unrelated.
Readmission of oxygen to hypoxic tissue can also elicit arrhythmias24,25,34; however, such studies are difficult to interpret owing to the absence of bona fide ischemia, the long duration of hypoxia used (more than 30 minutes), and the requirement in some studies34 for concurrent electrical stimulation of the tissue for arrhythmias to become manifest.
Third, it was recently demonstrated, on the basis of electron spin resonance spectrometric analysis of spin-adducts, that after a brief period of global ischemia, reperfusion elicits a burst of free radicals. 15, 35, 36 These free radicals were almost certainly derived from the oxygen readmitted during reperfusion, because their production was prevented by reperfusion with hypoxic solution; furthermore, readmission of oxygen after several minutes of hypoxic reperfusion resulted in de novo production of free radicals. 15 In the present study, we adapted Garlick's protocol15 to allow measurement of arrhythmias during hypoxic or anoxic reperfusion of regionally ischemic myocardium.
Evidence Against a Role for Oxygen-Derived Free Radicals in the Initiation of
Reperfusion-Induced Arrhythmias
Our data indicate that readmission of oxygen is not required for the initiation of reperfusion-induced arrhythmias. VT occurred in 100% of hearts within 3 seconds of reperfusion, irrespective of the Po2 of the perfusion solution (range, less than 0.0 to greater than 600 mm Hg). Furthermore, VF also occurred during the first 20-40 seconds of reperfusion; hypoxia delayed the time to onset of VF by up to about 20 seconds, but had no significant influence on VF incidence, even when Po2 was reduced to less than 0.0 mm Hg.
Interpretation of our results is critically dependent on our ability to control the Po2 of the solutions delivered to the ischemic tissue. We believe that such control was effectively achieved for two reasons. First, great care was taken to check the Po2 in samples of effluent from the coronary cannula at the beginning of each experiment at a flow equivalent to aortic flow. Second, when hypoxic or anoxic solutions were used for reperfusion they were introduced 15 seconds before reperfusion to ensure complete washout of control solution proximal to the coronary artery occlusion. Third, the partial pressure-dependent effects of readmission of normoxic solution (see below) can be explained only on the basis of the presence of hypoxia or anoxia during the initial reperfusion. Evidence for a Role for Oxygen-Derived Free Radicals in the Initiation of Reperfusion-Induced Arrhythmias Under Conditions in Which Other Arrhythmogenic Mechanisms Are Suppressed Reperfusion-induced VF in the rat heart, like that in the cat heart,37 can often terminate spontaneously, allowing sinus rhythm to resume.13 This property was exploited in the present study to allow us to examine whether readmission of oxygen could elicit arrhythmias in hearts initially reperfused with hypoxic or anoxic solution.
In a previous study, Garlick et a115 showed that readmission of oxygen could elicit a burst of oxygenderived free radical production after 5 minutes of hypoxic reperfusion. In an equivalent manner, readmission of oxygen after 5 minutes of hypoxic or anoxic reperfusion caused the appearance of new episodes of VT and VF in the present study. The incidence of arrhythmias was directly proportional to the degree of hypoxia present during the initial period of reperfusion (i.e., was inversely proportional to the previous Po2). Thus, when normoxia was restored after 5 minutes of anoxic reperfusion, new episodes of VF occurred in 100% of hearts.
The possibility that this arrhythmogenic effect was indirect (e.g., related to an abrupt change in heart rate) was examined. In hearts in which sinus rhythm resumed during hypoxic or anoxic reperfusion, sinus bradycardia developed. However, the arrhythmogenic effect of the subsequent readmission of oxygen was unrelated to any sudden increase in heart rate caused by reoxygenation of the sinoatrial node, because arrhythmias were elicited equally effectively when heart rate was held constant by ventricular pacing. Therefore, the arrhythmogenic effect of readmission of oxygen was direct (i.e., a consequence of some action in the myocardium). The previous observations of Garlick et a115 argue that the pathophysiological mechanism underlying the arrhythmias elicited by readmission of oxygen is oxygen-derived free radical production.
How Important Are Oxygen-Derived Free Radicals in the Initiation of Reperfusion-Induced Arrhythmias?
Our data showed that reperfusion-induced arrhythmias are not dependent on readmission of oxygen. Nevertheless, readmission of oxygen (as occurs during reperfusion) had an arrhythmogenic action that was independent of the readmission of coronary flow (which occurs during reperfusion).
We interpret these findings as follows. It is evident that reperfusion-induced arrhythmias are not caused solely by a burst of oxygen-derived free radicals. Other pathophysiological factors associated with reperfusion must be involved. Candidates include cyclic AMP,38 calcium influx from the extracellular milieu,39 and washout of extracellular potassium,40 although assessment of the relative importance of these factors is clearly beyond the scope of the present study.
It could be argued that these other factors alone are sufficient to account for arrhythmogenesis. However, the arrhythmogenic effects of readmission of oxygen (which occurred under conditions that have been previously shown to be associated with the production of oxygen-derived free radicals15) implies that oxygen-derived free radical production is equally arrhythmogenic and capable of contributing independently to arrhythmogenesis. Oxygen-derived free radicals and other arrhythmogenic factors must therefore operate in parallel to initiate reperfusion-induced arrhythmias. Neither can be regarded as playing the pivotal role in arrhythmogenesis.
Because both oxygen-dependent and oxygen-independent mechanisms appear to be sufficiently arrhythmogenic by themselves to account fully for the arrhythmogenicity of reperfusion, it would appear that reperfusion elicits arrhythmias with a "pathophysiological reserve." It follows from this that any intervention that has selective actions during reperfusion on oxygen-derived free radical formation or accumulation cannot be expected to possess antiarrhythmic activity; all other arrhythmogenic mecha-nisms operating during reperfusion would need to be suppressed for any antiarrhythmic effect of anti-free radical action to be revealed.
There are only three independent ways for an intervention that has specific actions on oxygenderived free radical formation or accumulation to ameliorate reperfusion-induced arrhythmias. First, the intervention would need to have a lack of selectivity (i.e., possess additional pharmacological properties conferring upon it the ability to ameliorate the mechanisms operating in parallel with oxygenderived free radicals). Second, the intervention would need to possess additional pharmacological properties, allowing it to inhibit the mechanisms operating in series with the pathophysiological determinants of reperfusion-induced arrhythmias (i.e., influence directly the cellular electrophysiological properties of the myocyte). Third, if the intervention is administered and present during the preceding period of ischemia, it may exert its beneficial effects via some anti-ischemic action. The explanation for the previously reported beneficial effects of anti-free radical interventions is likely to be a combination of the above. Of note, it should be reiterated that most agents reported to be effective have been administered throughout ischemia as well as during reperfusion, suggesting that antiarrhythmic activity may depend on anti-ischemic actions. Conclusion We have demonstrated that transient reperfusion with hypoxic and anoxic solutions, shown previously to be effective in abolishing the burst of oxygen-derived free radicals associated with normoxic reperfusion, was completely ineffective in preventing reperfusioninduced VT and VF. However, subsequent readmission of oxygen was capable of initiating VT and VF de novo. We conclude that readmission of flow and readmission of oxygen are independent determinants of reperfusion-induced arrhythmias. However, since readmission of flow was capable of initiating arrhythmias in the absence of readmission of oxygen, it is clear that reperfusion-induced arrhythmias are not caused solely by a burst of oxygen-derived free radicals. Any role that such a mechanism might play will become relevant only under conditions in which other mechanisms involved in the initiation of reperfusion-induced arrhythmias are suppressed. To answer the two questions posed in the first paragraph of the introduction relating to the pathophysiological basis of reperfusion-induced arrhythmias, 1) oxygen-derived free radical production does play an independent role in arrhythmogenesis, but 2) oxygen-derived free radical production does not play the principal or pivotal role in arrhythmogenesis.
